Opendata, web and dolomites

Dyneelax SIGNED

The world’s first automated laximetry device that replicates daily movements and activities through a dynamic test.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Dyneelax project word cloud

Explore the words cloud of the Dyneelax project. It provides you a very rough idea of what is the project "Dyneelax" about.

joints    anterior    standard    ligament    patients    recovery    roadmap    healthy    healthcare    quicker    sometimes    entirely    contact    market    injuries    periods    magnetic    mission    status    limited    injury    replacing    waiting    core    laxity    ray    clinical    first    sme    genourob    motion    overcome    diagnosing    lachman    emergency    claim    knee    prioritise    acl    substitute    components    imaging    cruciate    practitioners    instrument    treatment    body    function    contrast    orthopaedist    completing    transform    automated    medical    fragile    invasive    quantitative    resonance    specialists    reproducible    human    point    stabilising    standardisation    confirm    diagnosis    mechanised    gold    surveillance    ligaments    post    mri    dyneelax    carries    vital    gps    scans    grant    unpredictable    laximetry    ideal    device    looseness    exams    tests    scan    automation    prognosis    examinations    independent    protocol    diagnose    dynamic    wait    specialist    rotational    joint   

Project "Dyneelax" data sheet

The following table provides information about the project.

Coordinator
GENOUROB 

Organization address
address: BAT 60 RUE HENRI GERET
city: LAVAL
postcode: 53000
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-07-01   to  2019-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GENOUROB FR (LAVAL) coordinator 50˙000.00

Map

 Project objective

The knee is the largest, and one of the most complex and fragile joints in the human body, and the anterior cruciate ligament (ACL) is one of its core components. The ACL is vital to healthy knee function, stabilising the joint throughout its range of motion. In order to diagnose ACL injuries, the current gold standard is the Lachman’s test, which measures the ‘laxity’ (looseness) of the ligaments in the knee. Often done by hand, this is a reliable process when carried out by a specialist such as an orthopaedist. In contrast, general practitioners (GPs) and other non-specialists require x-ray or magnetic resonance imaging (MRI) exams to confirm their diagnosis. However, waiting periods for mechanised tests in the EU are long, sometimes entirely unpredictable, due to limited equipment availability and the need to prioritise emergency cases.

To overcome this, Genourob has developed Dyneelax, which is the first medical device for automated dynamic laximetry measurement. Dyneelax carries out objective and reproducible Lachman’s tests and rotational exams to assess the laximetry of the ACL. Automation and standardisation of this non-invasive, quantitative testing allows the diagnosis and prognosis of ACL injury and recovery status. It is independent of examinations such as x-ray and MRI scans and it can be used also by non-specialists such as GPs. This means quicker, more effective treatment for better recovery of patients.

At Genourob our mission is to transform the clinical protocol for diagnosing and prognosis of ACL injuries. In this way, GPs would be patients’ main point of contact with the healthcare system, replacing the need to wait for an MRI scan or x-ray for ACL injuries’ treatment. The SME Instrument grant is ideal for completing our product roadmap as it will enable our post-market surveillance to be carried out, to allow us to make the clinical claim that Dyneelax is an effective substitute for MRI scans in diagnosing and evaluating injuries to the ACL

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DYNEELAX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DYNEELAX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TuneFork (2018)

Mobile technology that brings personalized audio into your life

Read More  

PrasinoMed (2018)

First in the world ecological and sustainable cream for wound care, based on microalgaprasinococcus capsulatus

Read More  

GREEN WHS (2019)

NATURE FRIENDLY WATER HYDRAULIC STEERING SYSTEM

Read More